Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleni Gourni

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
EJNMMI Radiopharmacy and Chemistry|December 1, 2020
Effect of the versatile bifunctional chelator AAZTA<sup>5</sup> on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonistMichael Hofstetter, Euy Sung Moon, Fabio D'Angelo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2011
PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agentEleni Gourni, Oliver Demmer, Margret Schottelius, et al.
Journal of Medicinal Chemistry|December 5, 2014
Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumorsRosalba Mansi, Keelara Abiraj, Xuejuan Wang, et al.
Molecules (Basel, Switzerland)|July 13, 2024
Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)<sub>2</sub>Tilman Läppchen, Adrianna Bilinska, Eirinaios Pilatis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2018
Performance of <sup>111</sup>In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomyMichael Mix, Kathrin Reichel, Christian Stoykow, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2025
Improved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation studyAdrianna Bilinska, Sanjana Ballal, Chandrasekhar Bal, et al.
Cancers|July 24, 2021
Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?-An In Silico Study on the Role of Chronic Hypoxia in Prostate CancerGabriele Birindelli, Milos Drobnjakovic, Volker Morath, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2019
The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and gangliaIan Alberts, Christos Sachpekidis, Lotte Dijkstra, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 11, 2021
In silico study on radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapyGabriele Birindelli, Milos Drobnjakovic, Volker Morath, et al.
Journal of Medicinal Chemistry|June 16, 2009
Structural assessment and biological evaluation of two N3S bombesin derivativesEleni Gourni, Penelope Bouziotis, Dimitra Benaki, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
EJNMMI Radiopharmacy and Chemistry|December 1, 2020
Effect of the versatile bifunctional chelator AAZTA<sup>5</sup> on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonistMichael Hofstetter, Euy Sung Moon, Fabio D'Angelo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2011
PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agentEleni Gourni, Oliver Demmer, Margret Schottelius, et al.
Journal of Medicinal Chemistry|December 5, 2014
Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumorsRosalba Mansi, Keelara Abiraj, Xuejuan Wang, et al.
Molecules (Basel, Switzerland)|July 13, 2024
Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)<sub>2</sub>Tilman Läppchen, Adrianna Bilinska, Eirinaios Pilatis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2018
Performance of <sup>111</sup>In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomyMichael Mix, Kathrin Reichel, Christian Stoykow, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2025
Improved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation studyAdrianna Bilinska, Sanjana Ballal, Chandrasekhar Bal, et al.
Cancers|July 24, 2021
Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?-An In Silico Study on the Role of Chronic Hypoxia in Prostate CancerGabriele Birindelli, Milos Drobnjakovic, Volker Morath, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2019
The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and gangliaIan Alberts, Christos Sachpekidis, Lotte Dijkstra, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 11, 2021
In silico study on radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapyGabriele Birindelli, Milos Drobnjakovic, Volker Morath, et al.
Journal of Medicinal Chemistry|June 16, 2009
Structural assessment and biological evaluation of two N3S bombesin derivativesEleni Gourni, Penelope Bouziotis, Dimitra Benaki, et al.
Pageof 4